Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
Pharmacoeconomics
|
March 9, 1995
Teicoplanin. A pharmacoeconomic evaluation of its use in the treatment of gram-positive infections
C M Spencer, H M Bryson
Pharmacoeconomics
|
June 7, 1993
Tamoxifen: a review of pharmacoeconomic and quality-of-life considerations for its use as adjuvant therapy in women with breast cancer
H M Bryson, G L Plosker
Drugs
|
August 1, 1994
Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections
A J Wagstaff, H M Bryson
Drugs
|
August 1, 1994
Lacidipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension
C R Lee, H M Bryson
Drugs & Aging
|
June 1, 1996
Amitriptyline. A review of its pharmacological properties and therapeutic use in chronic pain states
H M Bryson, M I Wilde
Drugs
|
April 1, 1993
Cefetamet pivoxil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use
H M Bryson, R N Brogden
Drugs
|
March 1, 1997
Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders
A J Wagstaff, H M Bryson
Drugs & Aging
|
December 1, 1996
Liarozole
H M Bryson, A J Wagstaff
Pharmacoeconomics
|
December 9, 1993
Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF): an appraisal of its pharmacoeconomic status in neutropenia associated with chemotherapy and autologous bone marrow transplant
K L Goa, H M Bryson
Drugs
|
September 1, 1994
Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome
L R Wiseman, H M Bryson
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
Pharmacoeconomics
|
March 9, 1995
Teicoplanin. A pharmacoeconomic evaluation of its use in the treatment of gram-positive infections
C M Spencer, H M Bryson
Pharmacoeconomics
|
June 7, 1993
Tamoxifen: a review of pharmacoeconomic and quality-of-life considerations for its use as adjuvant therapy in women with breast cancer
H M Bryson, G L Plosker
Drugs
|
August 1, 1994
Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections
A J Wagstaff, H M Bryson
Drugs
|
August 1, 1994
Lacidipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension
C R Lee, H M Bryson
Drugs & Aging
|
June 1, 1996
Amitriptyline. A review of its pharmacological properties and therapeutic use in chronic pain states
H M Bryson, M I Wilde
Drugs
|
April 1, 1993
Cefetamet pivoxil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use
H M Bryson, R N Brogden
Drugs
|
March 1, 1997
Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders
A J Wagstaff, H M Bryson
Drugs & Aging
|
December 1, 1996
Liarozole
H M Bryson, A J Wagstaff
Pharmacoeconomics
|
December 9, 1993
Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF): an appraisal of its pharmacoeconomic status in neutropenia associated with chemotherapy and autologous bone marrow transplant
K L Goa, H M Bryson
Drugs
|
September 1, 1994
Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome
L R Wiseman, H M Bryson
Page
of 5